Alzamend Neuro, Inc. (ALZN) NASDAQ
1.12
+0.02(+1.82%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.36M |
| Enterprise Value | -1.58M |
| P/E Ratio | -0.59 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.91 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.11 |
Fiscal Year
| Fiscal Year | April 30, 2025 |
| Most Recent Quarter | January 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -1.74 |
| Return On Equity | -1.77 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -50,740 |
| EBITDA | -4.45M |
| Net Income | -4.51M |
| Diluted EPS | -11.32 |
Balance Sheet
| Total Cash | 2.71M |
| Total Cash/Share | 0.71 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 1.99 |
| Book Value Per Share | 0.57 |
Price History
| 52-Week Change | -82.19 |
| 52-Week High | 8.22 |
| 52-Week Low | 0.84 |
| Moving Average 50 Days | 1.6 |
| Moving Average 200 Days | 2.18 |
Statistics
| Average Volume | 140,606 |
| Shares Outstanding | 3.14M |
| % Held by Institutions | 6.35 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:9 |
| Last Split Date | May 12, 2025 |
